Fibroblast-Secreted Phosphoprotein 1 Mediates Extracellular Matrix Deposition and Inhibits Smooth Muscle Cell Contractility in Marfan Syndrome Aortic Aneurysm.
Mei ZhouYuexin ZhuZeyi ZhouFeiran QiShuai ZhengShijuan GaoYulin LiYan LiuJie DuPublished in: Journal of cardiovascular translational research (2022)
Fibrillin 1 (Fbn1) mutation causes Marfan syndrome (MFS) with thoracic aortic aneurysm (TAA) as the main complication. The mechanisms for extracellular matrix (ECM) homeostasis disruption in MFS TAA are unclear. Here, we found ECM-related gene secreted phosphoprotein 1 (Spp1) increased in Fbn1<sup>C1041G/+</sup> mice using transcriptome sequencing and a distinct fibroblast subcluster with Spp1 as the strongest marker was identified with analysis of the MFS mouse aortic single-cell sequencing dataset. Immunostaining confirmed elevated Spp1 in adventitial fibroblasts, and Spp1 might regulate fibroblast and smooth muscle cell (SMC) communication primarily through Itga8/Itgb1. Then, we observed Spp1 reduced contractile genes Acta2 and Tagln expression in SMCs and increased collagen expression in fibroblasts, which might contribute to TAA development. Finally, we also found elevated SPP1 plasma level was associated with an increased risk of TAA in patients. Therefore, SPP1 may serve as a biomarker and therapeutic target for TAA.
Keyphrases
- extracellular matrix
- smooth muscle
- single cell
- aortic aneurysm
- rna seq
- poor prognosis
- end stage renal disease
- spinal cord
- gene expression
- type diabetes
- skeletal muscle
- heart failure
- peritoneal dialysis
- case report
- coronary artery
- mesenchymal stem cells
- chronic kidney disease
- metabolic syndrome
- pulmonary artery
- prognostic factors
- left ventricular
- wound healing
- dna methylation
- insulin resistance
- patient reported